Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MidCap Financial Investment | MFIC | Nov 25, 2024 | 14.04 | +0.36 |
Midcap Growth Alphadex First Trust | FNY | Nov 25, 2024 | 88.28 | +1.10 |
Midcap Growth ETF Vanguard | VOT | Nov 25, 2024 | 270.38 | +0.64 |
Midcap Value Alphadex First Trust | FNK | Nov 25, 2024 | 58.28 | +1.59 |
Midcap Value ETF Vanguard | VOE | Nov 25, 2024 | 175.77 | +0.94 |
Middleby | MIDD | Nov 25, 2024 | 146.97 | +3.38 |
Middlefield Banc | MBCN | Nov 25, 2024 | 31.18 | -1.70 |
Middlesex Water | MSEX | Nov 25, 2024 | 67.88 | +2.08 |
Midland States Bancorp | MSBI | Nov 25, 2024 | 27.41 | +0.07 |
Midland States Bancorp Pref A | MSBIP | Nov 25, 2024 | 25.12 | +0.18 |
MidWestOne Financial Group | MOFG | Nov 25, 2024 | 33.26 | -1.31 |
Milestone Pharmaceuticals | MIST | Nov 25, 2024 | 1.85 | +0.54 |
Milestone Scientific | MLSS | Nov 25, 2024 | 0.79 | +2.20 |
Mill City Ventures | MCVT | Nov 25, 2024 | 1.82 | -4.21 |
Millennium Group International | MGIH | Nov 25, 2024 | 1.60 | +3.23 |
Miller Industries | MLR | Nov 25, 2024 | 73.66 | +2.41 |
Miller/Howard High Income Equity Fund | HIE | Nov 25, 2024 | 12.56 | 0.00 |
MillerKnoll | MLKN | Nov 25, 2024 | 25.53 | +4.08 |
Millicom International Cellular | TIGO | Nov 25, 2024 | 26.60 | +0.76 |
MiMedx Group | MDXG | Nov 25, 2024 | 9.09 | -1.20 |
MIND C.T.I. | MNDO | Nov 25, 2024 | 1.96 | 0.00 |
Mind Technology | MIND | Nov 25, 2024 | 3.90 | +1.83 |
MindMed | MNMD | Nov 25, 2024 | 7.61 | +0.66 |
Minerals Technologies | MTX | Nov 25, 2024 | 84.60 | +1.45 |
Mineralys Therapeutics | MLYS | Nov 25, 2024 | 12.70 | +1.68 |
Minerva Neurosciences | NERV | Nov 25, 2024 | 2.26 | +0.89 |
Mingteng International | MTEN | Nov 25, 2024 | 5.93 | -0.50 |
MingZhu Logistics | YGMZ | Nov 25, 2024 | 1.11 | +1.83 |
MINISO Group ADR | MNSO | Nov 25, 2024 | 16.90 | +1.32 |
MiNK Therapeutics | INKT | Nov 25, 2024 | 0.69 | +1.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.